TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.980
-0.030 (-0.75%)
Nov 4, 2024, 4:00 PM EST - Market closed

TriSalus Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-54.35-59.04-47.19-28.85-31.83
Depreciation & Amortization
0.750.70.40.460.32
Other Amortization
0.27--1.745.97
Loss (Gain) From Sale of Assets
0.190.230.31-00.04
Stock-Based Compensation
3.621.40.370.110.02
Other Operating Activities
2.315.9211.53.979
Change in Accounts Receivable
-2.59-1.98-0.2-0.74-0.42
Change in Inventory
-1.92-1.07-0.18-0.730.76
Change in Accounts Payable
-1.892.845.253.18-0.03
Change in Other Net Operating Assets
-0.990.95-2.57-1.840.59
Operating Cash Flow
-54.6-50.05-32.31-22.7-15.58
Capital Expenditures
-0.68-0.59-0.66-1.1-0.55
Cash Acquisitions
-1-1-1-1-
Sale (Purchase) of Intangibles
-0.47-0.53-0.13-0.16-0.16
Other Investing Activities
-----9
Investing Cash Flow
-2.14-2.12-1.79-2.26-9.7
Long-Term Debt Issued
---0.0525.48
Long-Term Debt Repaid
--0.09-0.13-1.35-0.7
Net Debt Issued (Repaid)
24.91-0.09-0.13-1.324.78
Issuance of Common Stock
6.870.180.090.050.01
Other Financing Activities
33.1335.72---
Financing Cash Flow
69.4254.6313.4650.7724.81
Net Cash Flow
12.682.46-20.6425.81-0.48
Free Cash Flow
-55.27-50.63-32.97-23.79-16.13
Free Cash Flow Margin
-223.44%-273.53%-265.91%-283.23%-296.74%
Free Cash Flow Per Share
-2.63-5.39-106.48-2.68-2.10
Cash Interest Paid
---0.020.05
Cash Income Tax Paid
0.010.010.010-
Levered Free Cash Flow
-52.96-51.81-0.15-24.49-
Unlevered Free Cash Flow
-52.67-51.8-0.15-25.13-
Change in Net Working Capital
23.1218.94-22.649.43-
Source: S&P Capital IQ. Standard template. Financial Sources.